News

Three Reasons You Should Participate in Clinical Trials

TOGA Researcher Clinical Trials

In the realm of medical breakthroughs, cancer clinical trials emerge as beacons of hope, guiding us toward innovative treatments and potential cures. These trials represent the frontlines of cancer research, where groundbreaking therapies are meticulously tested before reaching the hands of people living with lung cancer.

So, what exactly do these trials entail?

Cancer clinical trials are rigorous investigations conducted on a group of individuals to assess the safety and effectiveness of cancer treatments, ranging from cutting-edge medications to groundbreaking therapeutic approaches. In your journey through the landscape of healthcare, participating in cancer clinical trials becomes a transformative experience, offering not only the promise of progress but also a chance to be an active participant in shaping the future of cancer care.

Here are three compelling reasons why becoming a participant in cancer clinical trials is not only a noble endeavor but also a decision that can hold profound significance for you facing this formidable adversary:

1. Broadening Treatment Options

Cancer treatment is continually advancing with access to newer drugs and treatments. These medical advancements can only happen with the knowledge discovered through clinical trials. Clinical trials often test drugs or treatments that are not yet available in standard care. Participating in a trial may give you access to innovative treatments that could be more effective than standard care therapies. Clinical trials can provide access to additional therapies if you have limited treatment options. By participating in trials focused on your specific condition, you may gain access to therapies specifically tailored to address your unique medical needs.

2. Improving Treatment Outcomes

While participating in a clinical trial involves some level of uncertainty, it also offers the potential for better treatment outcomes. By testing new therapies or treatment strategies, clinical trials aim to improve upon existing standards of care and ultimately enhance patient survival rates and quality of life. Clinical trial patients often receive close monitoring and personalised care, which can lead to earlier detection of any issues and prompt intervention. Additionally, the structured nature of clinical trial participation, with its strict follow-up schedules and regular assessments, ensures that patients are closely monitored, potentially leading to better outcomes irrespective of the assigned treatment group.

3. Contributing to Future Discoveries

Your clinical trial participation may lead to discoveries that benefit not only yourself but also future cancer patients. By participating in a clinical trial, you become an active contributor to advancing cancer research and treatment development. Your experiences and outcomes contribute valuable data that can help researchers better understand the disease, identify new therapeutic targets, and refine treatment approaches for future patients. Every piece of information gathered during a clinical trial, whether it’s about treatment effectiveness, side effects, or patient responses, adds to the collective knowledge that drives progress in cancer care.

In conclusion, participating in cancer clinical trials is a meaningful way to contribute to the fight against cancer while potentially gaining access to cutting-edge treatments and improving treatment outcomes. By joining a clinical trial, you not only empower yourself but also play a vital role in shaping the future of cancer care for generations to come.

Where do I find clinical trials?

If you are interested in participating in clinical trials there are various resources to find trials that align with your medical condition and treatment preferences. The Australian Clinical Trials has the most comprehensive databases for finding clinical trials. Additionally, TOGA supports clinical trials for non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), mesothelioma, other thymic malignancies, supportive & palliative care, and translational research.

You can also consult with your healthcare providers, including oncologists and other specialists, who can provide guidance on available clinical trials in the context of your particular diagnosis. By leveraging these resources and collaborating with healthcare professionals, you can take proactive steps to explore clinical trial options and make informed decisions about your treatment journey.

Share this

Facebook
Twitter
LinkedIn
OCEANiC is a phase II multi-centre clinical trial targeting patients with resected stage II to IIIA EGFR mutant NSCLC. The trial provides access to Osimertinib
Facing a diagnosis can be a daunting journey, rife with uncertainty and difficult decisions. Among these decisions is the choice of whether to participate in
Recommendation by the Medical Services Advisory Committee (MSAC).